Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate Efficacy and Safety of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714 is registered in ClinicalTrials.gov with Mabwell (Shanghai) Bioscience Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate Efficacy and Safety of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Lead sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 15, 2025
- Completion date
- February 29, 2028
- Enrollment
- 360 (estimated)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease copd